GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) shares passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $21.07 and traded as low as $21.03. GENMAB A/S/S shares last traded at $21.29, with a volume of 860,581 shares trading hands.
GENMAB A/S/S Trading Down 0.8 %
The stock’s 50 day simple moving average is $21.07 and its 200 day simple moving average is $23.93.
GENMAB A/S/S Company Profile
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Recommended Stories
- Five stocks we like better than GENMAB A/S/S
- Comparing and Trading High PE Ratio Stocks
- MP Materials: Rare Earth Elements Powering the EV Boom
- What Are Dividend Challengers?
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- The How and Why of Investing in Gold Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
